A Phase I/II Study of the Safety and Efficacy of Sernova's Cell Pouch for Therapeutic Islet Transplantation

Trial Profile

A Phase I/II Study of the Safety and Efficacy of Sernova's Cell Pouch for Therapeutic Islet Transplantation

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 22 Dec 2016

At a glance

  • Drugs Islet cell replacement therapy (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions; Proof of concept
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 22 Dec 2016 According to a Sernova media release, this study is sponsored by JDRF.
    • 22 Dec 2016 According to a Sernova media release, update on the company's corporate and business strategy will be presented at the 9th annual Biotech Showcase Conference in San Francisco.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top